D.E. Shaw & Co’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,649
| Closed | -$44.1K | – | 3358 |
|
|
2023
Q4 | $44.1K | Sell |
10,649
-8,829
| -45% | -$36.6K | ﹤0.01% | 2824 |
|
|
2023
Q3 | $58.4K | Sell |
19,478
-23,239
| -54% | -$69.7K | ﹤0.01% | 2719 |
|
|
2023
Q2 | $105K | Sell |
42,717
-1,245
| -3% | -$3.06K | ﹤0.01% | 2689 |
|
|
2023
Q1 | $99.4K | Buy |
43,962
+28,290
| +181% | +$63.9K | ﹤0.01% | 2880 |
|
|
2022
Q4 | $54.7K | Sell |
15,672
-62,534
| -80% | -$218K | ﹤0.01% | 3188 |
|
|
2022
Q3 | $2.9M | Buy |
+78,206
| New | +$2.9M | ﹤0.01% | 1889 |
|
|
2022
Q2 | – | Sell |
-10,487
| Closed | -$283K | – | 4405 |
|
|
2022
Q1 | $283K | Buy |
+10,487
| New | +$283K | ﹤0.01% | 3472 |
|